Viridian Therapeutics, Inc. (VRDN)
NASDAQ: VRDN · Real-Time Price · USD
14.80
+0.14 (0.95%)
At close: Apr 17, 2026, 4:00 PM EDT
14.71
-0.09 (-0.61%)
After-hours: Apr 17, 2026, 7:52 PM EDT

Viridian Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1,5133,1691,5531,1761,207473
Market Cap Growth
42.03%104.09%32.05%-2.55%155.10%579.54%
Enterprise Value
690.62,4761,045925.17928.79409.85
Last Close Price
14.8031.1219.1721.7829.2119.77
PE Ratio
--9.37-6.24-5.57-10.78-2.97
PS Ratio
21.3544.735141.243744.64680.90159.63
PB Ratio
2.554.392.312.663.052.52
P/TBV Ratio
1.743.651.942.212.371.25
P/FCF Ratio
--11.44-6.67-6.35-6.52-5.00
P/OCF Ratio
--11.47-6.68-6.38-6.55-5.04
EV/Sales Ratio
9.7534.953458.742946.40524.15138.32
EV/EBITDA Ratio
--6.82-3.50-3.64-6.94-5.16
EV/EBIT Ratio
--6.81-3.49-3.64-6.92-5.14
EV/FCF Ratio
--8.94-4.49-5.00-5.02-4.33
Debt / Equity Ratio
0.070.070.030.050.010
Debt / EBITDA Ratio
-0.14-0.14-0.07-0.08-0.04-
Debt / FCF Ratio
-0.18-0.18-0.09-0.11-0.02-
Net Debt / Equity Ratio
-1.14-1.14-1.04-1.03-1.06-1.05
Net Debt / EBITDA Ratio
2.272.272.341.803.142.48
Net Debt / FCF Ratio
2.982.982.992.472.272.08
Asset Turnover
0.090.090.000.000.010.02
Quick Ratio
12.3712.3714.9917.9312.7314.48
Current Ratio
12.6512.6515.4318.2612.9314.68
Return on Equity (ROE)
-49.16%-49.16%-48.48%-56.80%-44.57%-51.61%
Return on Assets (ROA)
-44.27%-44.27%-48.51%-54.99%-42.05%-47.60%
Return on Invested Capital (ROIC)
1053.55%1053.55%1645.40%1420.99%922.32%1193.53%
Return on Capital Employed (ROCE)
-47.71%-47.71%-51.63%-58.80%-45.39%-51.33%
Earnings Yield
-18.64%-10.67%-16.01%-17.95%-9.28%-33.69%
FCF Yield
-18.30%-8.74%-15.00%-15.74%-15.34%-20.01%
Buyback Yield / Dilution
-24.92%-24.92%-51.68%-39.48%-169.22%-235.07%
Total Shareholder Return
-24.92%-24.92%-51.68%-39.48%-169.22%-235.07%
Updated Feb 26, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q